A mathematical model to improve Tumour Anti-Vascular Alpha Therapy (TAVAT) with 212 Pb-labelled monoclonal antibodies

2020 ◽  
Author(s):  
N Zaid ◽  
NJ Begum ◽  
P Kletting ◽  
AJ Beer ◽  
G Glatting
2021 ◽  
Author(s):  
Georgi I. Kapitanov

AbstractBlocking of IL-23 has shown a profound effect on patient outcomes in psoriasis. The current IL-23 binding monoclonal antibodies show differences in dosing regimens, pharmacokinetics, affinity for the target, and efficacy outcomes in the clinic. The goal of the current work is to use a mechanistic pharmacokinetics/pharmacodynamics mathematical model to estimate projected free IL-23 neutralization for the different therapeutic molecules and connect it to clinical efficacy outcomes. The meta-analysis indicates a sigmoid-like relationship and suggests that the best current anti-IL23 antibodies are close to saturating the efficacy that can be achieved by this pathway in psoriasis.


1984 ◽  
Vol 30 (9) ◽  
pp. 1523-1532 ◽  
Author(s):  
P H Ehrlich ◽  
W R Moyle

Abstract Mixtures of some monoclonal antibodies form circular antibody-antigen complexes, which facilitates their ability to bind antigen. This effect forms the basis of a potentially very sensitive assay procedure, the cooperative immunoassay (CIA). Unlike other immunoassays, in which binding can be characterized by a simple "binding constant," the binding of antigen by two antibodies in a CIA depends on several binding parameters, including the affinity of each antibody for antigen as well as the tendency of the reactants to form a circular complex. The ability of the CIA to distinguish between two similar molecules depends on the relative affinity of the antibodies for each antigen and on the ability of the antigens to participate in forming a circular complex. To study the binding of antibody mixtures to cross-reacting antigens, we devised a mathematical model to account for all possible antibody-antigen complexes, including those composed of circular complexes; however, we limited this model to the case in which one antibody was adsorbed to a solid phase. We illustrate here both theoretically and experimentally that a mixture of two antibodies in a CIA may have increased or decreased specificity, if circular complexes containing one or two molecules of cross-reacting antigen are formed. We discuss simple practical considerations that can help optimize specificity and sensitivity of solid-phase assays involving two monoclonal antibodies.


Author(s):  
James E. Crandall ◽  
Linda C. Hassinger ◽  
Gerald A. Schwarting

Cell surface glycoconjugates are considered to play important roles in cell-cell interactions in the developing central nervous system. We have previously described a group of monoclonal antibodies that recognize defined carbohydrate epitopes and reveal unique temporal and spatial patterns of immunoreactivity in the developing main and accessory olfactory systems in rats. Antibody CC2 reacts with complex α-galactosyl and α-fucosyl glycoproteins and glycolipids. Antibody CC1 reacts with terminal N-acetyl galactosamine residues of globoside-like glycolipids. Antibody 1B2 reacts with β-galactosyl glycolipids and glycoproteins. Our light microscopic data suggest that these antigens may be located on the surfaces of axons of the vomeronasal and olfactory nerves as well as on some of their target neurons in the main and accessory olfactory bulbs.


Author(s):  
K.S. Kosik ◽  
L.K. Duffy ◽  
S. Bakalis ◽  
C. Abraham ◽  
D.J. Selkoe

The major structural lesions of the human brain during aging and in Alzheimer disease (AD) are the neurofibrillary tangles (NFT) and the senile (neuritic) plaque. Although these fibrous alterations have been recognized by light microscopists for almost a century, detailed biochemical and morphological analysis of the lesions has been undertaken only recently. Because the intraneuronal deposits in the NFT and the plaque neurites and the extraneuronal amyloid cores of the plaques have a filamentous ultrastructure, the neuronal cytoskeleton has played a prominent role in most pathogenetic hypotheses.The approach of our laboratory toward elucidating the origin of plaques and tangles in AD has been two-fold: the use of analytical protein chemistry to purify and then characterize the pathological fibers comprising the tangles and plaques, and the use of certain monoclonal antibodies to neuronal cytoskeletal proteins that, despite high specificity, cross-react with NFT and thus implicate epitopes of these proteins as constituents of the tangles.


1996 ◽  
Vol 26 (10) ◽  
pp. 1182-1187 ◽  
Author(s):  
P. RESTANI ◽  
A. PLEBANI ◽  
T. VELONA ◽  
G. CAVAGNI ◽  
A. G. UGAZIO ◽  
...  

Ob Gyn News ◽  
2008 ◽  
Vol 43 (4) ◽  
pp. 12 ◽  
Author(s):  
GERALD G. BRIGGS

2008 ◽  
Author(s):  
Ishii Akira ◽  
Yoshida Narihiko ◽  
Hayashi Takafumi ◽  
Umemura Sanae ◽  
Nakagawa Takeshi
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document